IP Library Patent Application 11090743
Patent Application
App. No. 11/090,743

Thienodibenzoazulene compounds as tumor necrosis factor inhibitors

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/090,743
Abstract

The present invention relates to the dibenzoazulene compounds represented by formula I as well as to their pharmaceutical preparations for the inhibition of tumor necrosis factor alpha (TNF-α) and interleukine 1 (IL-1) in mammals at all diseases and conditions where these mediators are excessively secreted. The compounds of the present invention also demonstrate an analgetic action and can be used to relieve pain.

Claims (147)

1 . (canceled)

2 . (canceled)

3 . (canceled)

4 . (canceled)

5 . (canceled)

6 . (canceled)

7 . (canceled)

8 . (canceled)

9 . (canceled)

10 . (canceled)

11 . (canceled)

12 . (canceled)

13 . (canceled)

14 . (canceled)

15 . (canceled)

16 . A method for the treatment of inflammatory diseases and conditions induced by or associated with excessive production of TNF-α and/or IL-1, which comprises administering to a subject a therapeutically effective amount of a compound of formula I or a pharmacologically acceptable salt or hydrate thereof:

wherein

x represents CH 2 , or a heteroatom selected from the group consisting of O, S, S(═O), S(═O) 2 or NR 13

wherein R 13 is hydrogen, C 1-6 alkyl, C 1-6 alkylcarbonyl, arylcarbonyl, C 1-6 alkylsulfonyl, or arylsulfonyl;

each R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 independently represents hydrogen, fluoro, chloro, bromo; or C 1 -C 7 alkyl, C 2 -C 7 alkenyl; monocyclic or bicyclic aryl group having from 6 to 10 carbon atoms and alternating double bonds between carbon atoms and said aryl group can be unsubstituted or substituted with fluoro, chloro, bromo, hydroxy, C 1 -C 7 alkyl, C 1 -C 7 alkoxy, aryloxy, wherein aryl has the meaning as defined above, C 1 -C 7 alkylthio, arylthio wherein aryl has the meaning as defined above, C 1 -C 7 alkylsulfonyl, cyano, or amino; C 1 -C 7 mono or di-C 1 -C 7 substituted amino, heteroaryl which is a monocyclic or bicyclic aromatic hydrocarbon containing at least one heteroatom selected from O, S or N optionally said heteroaryl can be unsubstituted or substituted with fluoro, chloro, bromo, CF 3 , methyl, ethyl or propyl; or halomethyl, hydroxy, C 1 -C 7 alkoxy, aryloxy wherein aryl has the meaning as defined above, C 1 -C 7 alkylthio, arylthio wherein aryl has the meaning as defined above, C 1 -C 7 alkylsulfonyl, cyano, amino, C 1 -C 7 mono- or di-C 1 -C 7 substituted amino, C 1 -C 7 hydroxycarbonyl, C 1 -C 7 alkanoyloxycarbonyl, carbamoyl, mono-N-(C 1 -C 7 )alkylcarbamoyl, di-N,N-(C 1 -C 7 )alkylcarbamoyl, C 1 -C 7 alkyloxycarbonyl, aryloxycarbonyl, C 1 -C 7 alkylcarbonyl, arylcarbonyl;

R 10 represents C 2 -C 15 alkyl, C 2 -C 15 alkenyl, C 2 -C 15 alkynyl, aryl or heteroaryl wherein aryl and heteroaryl have the meaning as defined above, C 1 -C 15 haloalkyl, C 1 -C 15 hydroxyalkyl, C 1 -C 15 alkyloxy, C 1 -C 15 alkylthio, C 3 -C 15 alkylcarbonyl, C 2 -C 15 hydroxycarbonyl, C 3 -C 15 alkyloxycarbonyl, C 1 -C 15 alkylsulfonyl, arylsulfonyl or C 1 -C 15 alkylarylsulfonyl wherein aryl has the meaning as defined above, CH═CHCH 2 OH, CH═CHCH 2 O(CH 2 ) n -A, or C 1 -C 15 alkylamino represented by the formula

(CH 2 )n-A

wherein

n is an integer from 1 to 15, optionally one or more methylene groups can be substituted with an oxygen or sulphur atom A represents saturated or unsaturated a five- or six-membered ring having from one to three heteroatoms selected from the group consisting of O, S, N or combinations thereof, or a group of the formula

wherein

R 11 and R 12 independently represent hydrogen, C 1 -C 7 alkyl, C 2 -C 7 alkenyl, C 2 -C 7 alkynyl, aryl or heteroaryl wherein aryl and heteroaryl have the meaning as defined above, or a saturated or unsaturated five- or six-membered ring having from one to three heteroatoms selected from the group consisting of O, S, N or combinations thereof.

17 . The method of claim 16 wherein R 10 represents CH 2 OH, CH═CHCH 2 OH or CH 2 CH 2 CH 2 OH.

18 . The method of claim 16 wherein R 10 represents (CH 2 ) n A, CH 2 O(CH 2 ) n -A, CH═CHCH 2 O(CH 2 ) n -A or CH 2 CH 2 CH 2 O(CH 2 ) n -A.

19 . The method of claim 16 wherein A represents morpholine-4-yl, piperidine-1-yl or pyrrolidine-1-yl.

20 . The method of claim 16 wherein A represents

wherein R 11 and R 12 are as defined in claim 16 .

21 . The method of claim 16 wherein R 11 and R 12 represent H, —CH 3 or —CH 2 CH 3 .

22 . The method of claim 16 wherein R 2 represents H, SCH 3 , F, Cl, Br or CH 3 .

23 . The method of claim 16 wherein R 3 represents H, OCH 3 , F, Cl, Br, CF 3 or CH 3 .

24 . The method of claim 16 wherein R 4 represents H, F, Cl or CH 3 .

25 . The method of claim 16 wherein R 6 represents H, F or Cl.

26 . The method according to claim 16 wherein R 10 represents C 1 -C 15 hydroxyalkyl, or C 2 -C 15 alkylamino represented by the formula

(CH 2 ) n -A.

27 . The method of claim 26 wherein said heteroaryl group is selected from the group consisting of thiophene, pyrrole, imidazole, pyridine, oxazole, thiazole, pyrazole, tetrazole, pyrimidine, pyrazine and triazine.

28 . The method of claim 16 wherein said heteroaryl group is selected from the group consisting of thiophene, pyrrole, imidazole, pyridine, oxazole, thiazole, pyrazole, tetrazole, pyrimidine, pyrazine and triazine.

29 . The method of claim 16 wherein the compound of formula I is selected from the group consisting of:

dimethyl-[3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine hydrochloride,

dimethyl-[2-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine hydrochloride,

4-[2-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,

1-[2-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,

1-[2-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,

[3-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine,

[2-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine,

4-[2-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine,

1-[2-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine,

1-[2-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,

[3-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine,

[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine,

4-[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine,

1-[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine,

1-[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,

[3-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

4-[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,

1-[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,

1-[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,

[3-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[2-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

4-[2-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,

1-[2-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,

1-[2-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,

[3-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[2-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

4-[2-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,

1-[2-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,

1-[2-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,

[3-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[2-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

4-[2-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,

1-[2-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,

1-[2-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,

[3-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[2-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

4-[2-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine,

1-[2-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine,

1-[2-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,

[3-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine, dimethyl-[2-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine hydrochloride,

4-[2-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine,

1-[2-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,

1-[2-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,

[3-(10-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine,

[2-(10-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

1-[2-(10-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,

1-[2-(10-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,

[3-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[2-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

1-[2-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,

1-[2-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,

[2-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[3-(9,11-dimethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[2-(9,11-dimethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

1-[2-(9,11-dimethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,

[3-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[2-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

4-[2-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,

1-[2-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,

1-[2-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,

[3-(9-chloro-11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,

[2-(9-chloro-11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,

4-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-but-3-ene-2-one,

4-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-but-3-ene-2-one,

3-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-acrylic acid,

3-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-propionic acid,

3-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propylamine,

3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propylamine,

N,N-dimethyl-[3-(11-methylsulfanyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N,N-dimethyl-[2-(11-methylsulfanyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,

N,N-dimethyl-[3-(10-methyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N,N-dimethyl-[2-(10-methyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,

N,N-dimethyl-[3-(11-methyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N,N-dimethyl-[2-(11-methyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,

N,N-dimethyl-[3-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N,N-dimethyl-[2-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,

1-(2-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine,

1-(2-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,

3-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propylamine,

N,N-dimethyl-[3-(6-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N,N-dimethyl-[2-(6-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,

3-(6-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N,N-dimethyl-[3-(10-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N,N-dimethyl-[2-(10-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,

[2-(3-dimethylamino-propoxymethyl)-1-thia-8-aza-dibenzo[e,h]azulene-8-yl)-phenyl-methanon,

[2-(2-dimethylamino-ethoxymethyl)-1-thia-8-aza-dibenzo[e,h]azulene-8-yl)-phenyl-methanon,

N,N-dimethyl-[3-(8H-1-thia-8-aza-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N,N-dimethyl-[2-(8H-1-thia-8-aza-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,

[3-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propylamine hydrochloride,

[3-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy]-propylamine,

N,N-dimethyl-{3-[3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-propyloxy]-propyl}-amine,

N,N-dimethyl-{2-[3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-propyloxy]-ethyl}-amine,

N,N-dimethyl-{3-[3-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-propyloxy]-propyl}-amine,

N,N-dimethyl-{2-[3-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-propyloxy]-ethyl}-amine,

N,N-dimethyl-{3-(8H-1-thia-dibenzo[e,h]azulene-2-yl)-methoxy]-propyl}-amine,

N,N-dimethyl-{2-(8H-1-thia-dibenzo[e,h]azulene-2-yl)-methoxy]-ethyl}-amine,

N,N-dimethyl-{3-[3-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-allyloxy]-propyl}-amine,

N,N-dimethyl-{2-[3-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-allyloxy]-ethyl}-amine,

N-methyl-[3-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N-methyl-[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,

N-methyl-[3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

N-methyl-[3-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,

2-bromomethyl-1,8-dithia-dibenzo[e,h]azulene, and

2-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-ethylamine, and salts and hydrates thereof.

30 . The method of claim 16 wherein the compound of formula I is [2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine.

Assignments (1)
CHANGE OF NAME Recorded Sep 18, 2006
From: PLIVA-ISTRAZIVACKI INSTITUT D.O.O.
To: GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O.
Reel/Frame 018260/0944 →